Please click here to read our COVID-19 policies and resources before your visit or appointment. X
Jump to:  A   |   B   |   C   |   D   |   E   |   F   |   G   |   H   |   I   |   J   |   K   |   L   |   M   |   N   |   O   |   P   |   Q   |   R   |   S   |   T   |   U   |   V   |   W   |   X   |   Y

Pfizer Vaccine Prevents 91% of Symptomatic COVID in Young Children: FDA

Pfizer Vaccine Prevents 91% of Symptomatic COVID in Young Children: FDA

SATURDAY, Oct. 23, 2021 (HealthDay News) -- Two doses of the Pfizer-BioNTech COVID-19 vaccine is nearly 91% effective in preventing symptomatic illness in young children and brings no unexpected safety issues, according to a study posted Friday by the U.S. Food and Drug Administration.

Late Friday, the agency posted its analysis of data from Pfizer's pediatric study and said that in nearly all models, the health benefits of administering kid-sized doses of the shot to America's 28 million 5- to 11-year-olds far outweighs any potential side effects, the Associated Press reported.

The FDA will have a panel of independent experts offer advice on the use of the Pfizer vaccine in elementary school-age children next Tuesday, and a decision from the agency could come soon after. If the U.S. Centers for Disease Control and Prevention agrees, experts there would offer further guidance on a vaccine rollout to children under 12 -- meaning that shots for young children could be administered as soon as early November, the AP said.

Children age 12 and older already have access to the Pfizer COVID-19 vaccine, but uptake by younger kids could help prevent rare cases of symptomatic illness and also greatly stem transmission, since children in this age group are thought to be conduits of new infections to adults.

The pediatric data submitted to the FDA by Pfizer was largely compiled in August and September, when the highly contagious Delta variant was already the dominant form of virus within the United States, the AP noted. Two doses of the vaccine appeared to prevent 9 out of 10 cases of symptomatic illness in young kids, with no surprises in terms of side effects, which appeared limited to sore arms, fever and achiness.

The FDA noted that the study population was not large enough to assess the risk of side effects such as myocarditis, an inflammation of the heart that has been seen in very rare cases in adults.

In four different modeling scenarios, uptake of the vaccine by young children clearly prevented many more hospitalizations than might be caused through side effects, the FDA said.

According to the AP, severe COVID is extremely rare in young children. The latest data from the American Academy of Pediatrics estimates that nearly 6.2 million American children have been infected with SARS-CoV-2 so far, resulting in a total of 630 deaths in people age 18 and under.

A large supply of millions of specially labeled pediatric doses of the Pfizer vaccine have already been stockpiled by the Biden administration, and are ready for shipment throughout the country, the AP said. More than 25,000 pediatricians and primary care providers are enlisted to administer the shots.

More information:

Find out more about COVID-19 vaccines and children at the U.S. Centers for Disease Control and Prevention.

SOURCE: Associated Press

Reviewed Date: --

Find a pediatrician
Infectious Diseases
Dr. Randall Fisher
Dr. Laura Sass
Health Tips
Abuse of Prescription ADHD Medicines Rising on College Campuses
Guidelines for Raising Smoke-Free Kids
Helping Kids Get Over their Fears
Parenting Déjà vu: Raising Your Grandchildren
Parents-to-Be Must Communicate
Reading to Kids Helps Their Development
Talking About Sex with Your Teen
Talking With Your Kids About Drugs, Alcohol, and Tobacco
When Can a Child Wear Contact Lenses
Quizzes
Immunization Quiz
Vaccine Quiz
NewsLetters
Are You a Tired Mom? 4 Tips to Sleep Better
Diseases & Conditions
Anatomy of a Child's Brain
Anatomy of the Endocrine System in Children
Anxiety Disorders in Children
Asthma in Children Index
Becker Muscular Dystrophy (BMD) in Children
Bone Marrow Transplant for Children
Brain Tumors in Children
Chemotherapy for Children: Side Effects
Discipline
Ewing Sarcoma in Children
Firearms
Hepatitis B Virus (HBV) in Children
Inflammatory and Infectious Musculoskeletal Disorders
Inflammatory and Infectious Neurological Disorders
Inguinal Hernia in Children
Insect Bites and Children
Kidney Transplantation in Children
Meningitis in Children
Mood Disorders in Children and Adolescents
Myasthenia Gravis (MG) in Children
Osteosarcoma (Osteogenic Sarcoma) in Children
Pediatric Blood Disorders
Post-Traumatic Stress Disorder (PTSD) in Children
Preparing the School-Aged Child for Surgery
Schizophrenia in Children
School-Aged Child Nutrition
Sports Safety for Children
Superficial Injuries of the Face and Head- Overview
Television and Children
Thalassemia
The Growing Child: 2-Year-Olds
The Heart
The Kidneys
Your Child's Asthma
Your Child's Asthma: Flare-ups

Disclaimer: This information is not intended to substitute or replace the professional medical advice you receive from your child's physician. The content provided on this page is for informational purposes only, and was not designed to diagnose or treat a health problem or disease. Please consult your child's physician with any questions or concerns you may have regarding a medical condition.